Ronen Stoff

Oncology

200 1st St Sw
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma.

Clinical and Radiometabolic Correlatives of ddPCR Liquid Biopsy for BRAF V600 Mutated Melanoma.

Journal: International journal of cancer

Published: October 23, 2025

Outcomes in Patients With Immune Checkpoint Inhibitor-Related Myopathy and Prolonged Follow-Up.

Outcomes in Patients With Immune Checkpoint Inhibitor-Related Myopathy and Prolonged Follow-Up.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: October 06, 2025

Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy.

Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy.

Journal: Therapeutic advances in medical oncology

Published: September 11, 2025

ASO Author Reflections: Is PET/CT Response Assessment After Neoadjuvant Systemic Therapy for Stage III Melanoma Enough?

ASO Author Reflections: Is PET/CT Response Assessment After Neoadjuvant Systemic Therapy for Stage III Melanoma Enough?

Journal: Annals of surgical oncology

Published: August 13, 2025

Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment.

Accuracy of PET-CT to Assess the Extent of Nodal Disease in Patients with Clinical Stage III Melanoma Following Neoadjuvant Treatment.

Journal: Annals of surgical oncology

Published: June 19, 2025

Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting.

Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting.

Journal: Melanoma research

Published: August 29, 2024

Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy.

Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy.

Journal: Melanoma research

Published: June 24, 2024

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.

Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma.

Journal: Neurology

Published: August 31, 2023

Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.

Neoadjuvant BRAF-targeted therapy for ameloblastoma of the mandible: an organ preservation approach.

Journal: Journal of the National Cancer Institute

Published: June 15, 2023

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma.

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma.

Journal: Frontiers in oncology

Published: April 13, 2023

Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy.

Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy.

Journal: Cancers

Published: March 26, 2023

Fecal Microbiota Transplantation as a Cancer Therapeutic.

Fecal Microbiota Transplantation as a Cancer Therapeutic.

Journal: Cancer journal (Sudbury, Mass.)

Published: March 23, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026